12:00 AM
 | 
Feb 11, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

S-555739: Phase III started

Shionogi disclosed in its 3Q12 earnings for the period ending Dec. 31, 2012, that it began a double-blind, Japanese Phase III...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >